Tucatinib-d6

SL-10056

Tucatinib-d₆, >98%

Related CAS No. : [937263-43-9] of the unlabelled compound

Synonyms : ARRY-380-d₆; ONT-380-d₆

IUPAC Name : N4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-bis(methyl-d₃)-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Tucatinib, which is a potent, orally active and selective HER2 inhibitor. Tucatinib is an anticancer medication used to treat certain types of HER2-positive breast cancer and colorectal cancer.

References : Moulder-Thompson S. et al.: Clin Cancer Res., 23(14), 3529-3536, 2017.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.